Published guidelines recommend continuing β-adrenergic receptor blockade in patients undergoing stress testing. We evaluated the role of pharmacological versus exercise stress testing in achieving target heart rate (THR) among patients on β-adrenergic blockade. We compared data from 140 patients who underwent dobutamine stress echo (DSE) and 143 patients who underwent exercise treadmill testing (ETT). In both groups, β-adrenergic blocker was continued at the time of stress testing. Overall, patients undergoing DSE achieved THR more frequently than ETT. With β-adrenergic blockade, DSE patients met THR more frequently than ETT patients (p < 0.001). Without β-adrenergic blockade, there was no difference between either modality in achieving THR. In both DSE and ETT patients, absence of β-adrenergic blockade increased the odds of achieving THR [odds ratio (OR): 2.46, p = 0.042 and OR: 7.44, p < 0.001, respectively]. Atropine use with DSE increased the odds of achieving THR (OR: 3.76, p = 0.006). In conclusion, pharmacological stress testing appears to be superior to exercise stress testing in achieving THR among patients on β-adrenergic blockade.

Keywords:
Dobutamine, Echo, Treadmill, Target, Beta-Blocker
1.
ACC/AHA Guidelines for Exercise Testing: Exercise testing to diagnose obstructive coronary artery disease. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). Circulation 2002;106:1883–1892.
2.
Lee TH, Boucher CA: Clinical practice. Noninvasive tests in patients with stable coronary artery disease. N Engl J Med 2001;344:1840–1845.
3.
Gauri A, Raxwal V, Roux L, Fearon W, Froelicher V: Effects of chronotropic incompetence and beta-blocker use on the exercise treadmill test in men. Am Heart J 2001;142:136–141.
4.
Marcovitz P, Armstrong W: Impact of metoprolol on heart rate, blood pressure, and contractility in normal subjects during dobutamine stress echocardiography. Am J Cardiol 1997;80:386–388.
5.
Ho S, McComish M, Taylor R: Effect of beta-adrenergic blockade on the results of exercise testing related to the extent of coronary artery disease. Am J Cardiol 1985;55:258–262.
6.
Freemantle N, Cleland J, Young P, et al: β-Blockade after myocardial infarction: systematic review and meta-regression analysis. Br Med J 1999;318:1730.
7.
Psaty BM, Koepsell TD, LoGerfo JP, et al: β-Blockers and primary prevention of coronary heart disease in patients with high blood pressure. JAMA 1989;261:2087.
8.
Mangano DT, Layug EL, Wallace A, Tateo I: Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 1996;335:1713–1720.
9.
Ferguson TB Jr, Coombs LP, Peterson ED: Perioperative beta-blocker use and mortality and morbidity following CABG surgery in North America. JAMA 2002;287:2221–2227.
10.
Humma LM, Richardson HE, Lewis JF, McGorray SP, Pepine CJ, Johnson JA: Dobutamine pharmacodynamics during dobutamine stress echocardiography and the impact of beta-blocker withdrawal: a report from the Women’s Ischemic Syndrome Evaluation Study. Pharmacotherapy 2002;22: 939–946.
11.
Fletcher GF, Balady GJ, Amsterdam EA, et al: Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation 2001;104:1694.
12.
Sitges M, Pare C, Azqueta M, Bosch X, Miranda-Guardiola F, Velamazan M, et al: Feasibility and prognostic value of dobutamine stress echocardiography early in unstable angina. Eur Heart J 2000;21:1063–1071.
13.
Ling LH, Pellikka PA, Mahoney DW, Mahoney DW, Oh JK, McCully RB, et al: Atropine augmentation in dobutamine stress echocardiography: role and incremental value in a clinical practice setting. J Am Coll Cardiol 1996;28:551–557.
14.
Fioretti PM, Poldermans D, Salustri A, Forester T, Bellotti E, McNiell J, et al: Atropine increases the accuracy of dobutamine stress echocardiography in patients taking beta-blockers. Eur Heart J 1994;15:355–360.
15.
Zaglavara T, Haaverstad R, Cumberledge B, Irvine T, Karvonuis H, Parharidis G, et al: Dobutamine stress echocardiography for the detection of myocardial viability in patients with left ventricular dysfunction taking beta-blockers: accuracy and optimal dose. Heart 2002;87:329–335.
16.
Munagala VK, Guduguntla V, Kasravi B, Cummings G, Gardin JM: Use of atropine in patients with chronotropic incompetence and poor exercise capacity during treadmill stress testing. Am Heart J 2003;145:1046–1050.
17.
Jost C, Pellikka P: Atropine for inconclusive exercise tests: a beautiful solution or just cosmetics? Am Heart J 2003;145:938–939.
18.
Variola A, Albierto R, Dander B, et al: The exercise test with atropine. G Ital Cardiol 1997;27:255–262.
19.
Diercks DB, Kirk JD, Turnipseed SD, Amsterdam EA: Utility of immediate exercise treadmill testing in patients taking beta-blockers or calcium channel blockers. Am J Cardiol 2002;90:882–885.
© 2005 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.